Position in A
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,474,267
+$1,199,501 QoQ
Shares Held
48,741
+5.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#262
of 1,112 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. A ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
This page
|
48,741 | $6,474,267 |
All Filings in A
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,474,267 | 48,741 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,274,766 | 46,278 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,489,722 | 47,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,106,661 | 39,787 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,867,187 | 32,770 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,242,513 | 36,267 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,506,300 | 33,544 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,161,029 | 41,494 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,248,070 | 40,485 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $4,757,303 | 32,694 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $431,549 | 3,104 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $615,233 | 5,502 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $707,551 | 5,884 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,288,913 | 9,317 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $873,656 | 5,838 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $272,879 | 2,245 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $292,174 | 2,460 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $323,943 | 2,448 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $595,015 | 3,727 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $579,710 | 3,680 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $673,422 | 4,556 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $445,117 | 3,501 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $534,389 | 4,510 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||